搜索临床试验以:Infusion
总计4980个结果
-
University of CalgaryCanadian Institutes of Health Research (CIHR); Roche Pharma AG完全的
-
Northwestern UniversityAnn & Robert H Lurie Children's Hospital of Chicago完全的
-
Melbourne HealthNational Health and Medical Research Council, Australia; Bristol-Myers Squibb终止
-
Children's Mercy Hospital Kansas City完全的
-
Aegera TherapeuticsChinese University of Hong Kong完全的
-
Aegera TherapeuticsThe Leukemia and Lymphoma Society终止
-
INSYS Therapeutics Inc完全的
-
Fondazione Italiana Sindromi Mielodisplastiche-ETSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte终止
-
National Institute of Allergy and Infectious Diseases...完全的
-
Ministry of Health, Labour and Welfare, Japan未知
-
Cooperative Study Group A for Hematology完全的
-
Medtronic Hellas Medical Devices ΑEE未知
-
INSYS Therapeutics Inc完全的
-
INSYS Therapeutics Inc完全的
-
INSYS Therapeutics Inc完全的
-
Stanford UniversityNational Institutes of Health (NIH); Amgen完全的淋巴瘤,非霍奇金 | 淋巴瘤:非霍奇金 | 淋巴瘤:非霍奇金外周 T 细胞 | 淋巴瘤:非霍奇金皮肤淋巴瘤 | 淋巴瘤:非霍奇金弥漫性大 B 细胞 | 淋巴瘤:非霍奇金滤泡性/惰性 B 细胞 | 淋巴瘤:非霍奇金套细胞 | 淋巴瘤:非霍奇金边缘区 | 淋巴瘤:非霍奇金华氏巨球蛋白血症美国
-
Bharat Serums and Vaccines LimitedMinistry of Science and Technology完全的
-
Mayo ClinicNovo Nordisk A/S完全的
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group完全的
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group完全的
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group完全的淋巴瘤 | 骨髓增生异常综合征 | 白血病 | 慢性骨髓增生性疾病 | 未明确的成人实体瘤,特定方案 | 多发性骨髓瘤和浆细胞肿瘤 | 癌前/非恶性疾病美国
-
Theradex未知
-
Medical Centre LeeuwardenLithuanian University of Health Sciences完全的